In 2026, Archo Medical successfully completed the first-in-human clinical use of the EndoHub™ platform, achieving 100% technical success across five implants in three patients with complex iliac aneurysms. All devices were delivered and deployed as intended, with preservation of target vessels and no immediate device-related adverse events.
The procedures demonstrated the feasibility of the innovative multi-lumen connector stent-graft concept, developed to expand endovascular treatment options for patients with complex anatomies. This milestone represents an important step in the clinical validation of the EndoHub™ platform and reinforces its potential as a novel solution for the treatment of aneurysms and other complex aortic diseases. -
Clinical trial